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Abstract
Inappropriate activation or inadequate regulation of CD4+ and CD8+ T cells may contribute
to the initiation and progression of multiple autoimmune and inflammatory diseases. Studies
on disease-associated genetic polymorphisms have highlighted the importance of biological
context for many regulatory variants, which is particularly relevant in understanding the
genetic regulation of the immune system and its cellular phenotypes. Here we show cell
type-specific regulation of transcript levels of genes associated with several autoimmune
diseases in CD4+ and CD8+ T cells including a trans-acting regulatory locus at chr12q13.2
containing the rs1131017 SNP in the RPS26 gene. Most remarkably, we identify a common
missense variant in IL27, associated with type 1 diabetes that results in decreased func-
tional activity of the protein and reduced expression levels of downstream IRF1 and STAT1
in CD4+ T cells only. Altogether, our results indicate that eQTL mapping in purified T cells
provides novel functional insights into polymorphisms and pathways associated with auto-
immune diseases.
Author summary
Variation in regulatory regions as well as coding regions of the genome can affect the
expression of genes. Many of these variants have been associated with different diseases
and other traits, but the underlying biological pathways are often left unknown. Analysing
the effect of single nucleotide polymorphisms (SNPs) on gene expression levels, referred
to as expression quantitative trait loci (eQTL), in specific cell types can be used to gain
insight into specific mechanisms of disease. By analyzing eQTLs in CD4+ and CD8+ T
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cells, essential elements of adaptive immune response, we identified both cis- and trans-
acting SNPs in genes associated with several autoimmune diseases.
Introduction
T cells are essential elements of the adaptive immune response [1]. CD4+ T cells, together with an
appropriate cytokine environment, are required for the activation and differentiation of CD8+ T
cells that mediate defense and pathogen clearance during various infections [2]. The role of CD4+
T cells is also necessary for B cells and macrophages to execute their protective functions.
T cells are activated and start to differentiate in response to complex stimuli involving cyto-
kines, membrane receptors and transcription factors. Signaling through T cell receptor and costi-
mulatory molecules induces their rapid proliferation and clonal expansion, and differentiation
into effector and memory T cell subtypes [3]. Faulty activation or inadequate regulation of CD4+
and CD8+ T cells may contribute to the initiation and progression of multiple autoimmune dis-
eases, including type 1 diabetes (T1D), rheumatoid arthritis (RA), autoimmune thyroiditis, sys-
temic lupus erythematosus (SLE), multiple sclerosis, psoriasis, inflammatory bowel disease, as well
as allergy and asthma [4,5]. In addition, a distinct lineage of CD4+ T cells, regulatory T cells, have
a central role in the control of the pathogenesis of autoimmune and inflammatory diseases [6].
Genome-wide association studies (GWAS) have identified thousands of single nucleotide
polymorphisms (SNPs) associated with various immune related diseases [7–12]. Studies of the
consequences of the risk alleles in biologically relevant contexts for different diseases have
stressed the importance of the tissue and cell type-specificity of the regulatory variants [13–15].
We have recently shown that by mapping eQTLs in a sufficiently large sample set, it is possible to
identify cell type-specific effects in whole blood, but the challenge to distinguish the cells respon-
sible for the associations remains [16,17]. The power of studying expression-associated genetic
variants in purified cells types has now been illustrated for B cells, monocytes, neutrophils, T reg-
ulatory cells and CD4+ T cells [18–21], which allowed the identification of functional roles for
several polymorphisms at autoimmune and even neurodegenerative disease loci. Meanwhile,
some particularly interesting cis- and trans-eQTLs identified in whole blood could not be attrib-
uted to these cell types, and require an expanded survey of cells involved in immune response.
To this end, we purified CD4+ and CD8+ T cells from the peripheral blood of 313 healthy
individuals for genome-wide mapping of genetic variation affecting the expression of genes
involved in immune response. Our analysis characterizes both the extent of genetic control of
gene expression in T cells and its cellular specificity, as well as variation in isoform levels of
genes and their association with epigenetic changes. We show that integrating knowledge
from GWAS with eQTLs enables us to clarify the functional consequences of disease-associ-
ated variants and assess the enrichment of autoimmune response. Finally, we highlight a com-
mon T1D-associated missense variant in IL27 affecting the STAT1 and IRF1 pathway in CD4+
T cells. Our analysis provides insights into the basic processes of the regulation of gene expres-
sion in T cells and advances our understanding about the pathways involved with disease sus-
ceptibility in the adaptive immune system.
Results
Genetic control of gene expression in T cells
We purified CD4+ and CD8+ T cells from peripheral blood mononuclear cells (PBMCs) of 313
healthy European individuals from the Estonian Biobank [22]. The purified cells were subjected
eQTL analysis of CD4+ and CD8+ T cells
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to genome-wide gene expression analysis, genotyping and imputation using the 1000 Genomes
reference panel. After stringent quality control and filtering, close to 6 million SNPs, and
expression data from 38,839 probes within 23,704 genes were included in the analysis. DNA
methylation of 450,000 CpG sites was determined in the same purified cells of 100 of the indi-
viduals [23] to add explanations to observed differential expression between cell types.
To characterize the extent of genetic control of gene expression in T cells and its cellular
specificity, we first tested the association between SNPs and gene expression within 1Mb inter-
vals, referred to as cis-eQTLs. In total, we identified cis regulatory SNPs for 2,605 genes in
CD4+ T cells and 2,056 genes in CD8+ T cells at probe-level false discovery rate (FDR) < 0.05
(Fig 1A, S1 Table), with an overlap of 1,637 genes and estimated replication rate π1 = 0.99.
The high replication rate reflects the similarity of the two cell types compared, and also high-
lights the limitations of arbitrary cut-off levels for significance. Moreover, about half of the sig-
nificant eQTLs detected in a large meta-analysis of peripheral blood from 5000 individuals
[16] could be replicated in the CD4+ and CD8+ T cells (π1 = 0.51 and 0.45, respectively, S1
Fig), indicating a high level of T cell-specific eQTL effects [24,25]. As examples of cis-eQTLs in
CD4+ and CD8+ T cells, we observed evidence of genetic regulation of long coding RNA RP11
−534L20.5 located 7 kb downstream of the IKBKE gene which has an essential role in regulat-
ing inflammatory responses to viral infections; STAT6, a transcriptional activator involved in
T cell differentiation, and STX2 (syntaxin 2), involved in intracellular transport of vesicles
(Fig 1B).
Cell type-specificity of eQTLs
We next used a Bayesian model averaging and hierarchical modelling [26] that combines
information across genes to jointly call eQTLs in one framework to assess the specificity and
proportion of shared eQTLs in CD4+ and CD8+ T cells. Of 3871 genes associated with eQTLs,
all showed very strong posterior probability to be shared between CD4+ and CD8+ T cells (S2
Table).
One of the strengths of the multi-tissue joint cis-eQTL analysis is its capability to account
for incomplete power [26,27]. As our sample size for both of the cell types was similar, we
noted the advantage of Bayesian methods in particular for genes with eQTLs that have modest
effects. Moreover, for eQTLs where the absolute effect size was higher in one cell type, there
was also a tendency for higher expression levels in that gene in the given cell type (chi-square
test P-value < 2x10-16, S2 Fig). For a standard tissue-by-tissue analysis, higher effect sizes and
small standard deviations lead to more statistical evidence against the null, thus resulting in
lower P-values.
The effect of the magnitude of the expression levels is exemplified by the effect sizes and P-
values of the probes in the inhibitory immune checkpoint gene, CTLA4, known to be associated
with T1D and other endocrine autoimmune diseases [28,29]. CTLA4 is covered by three probes
all showing consistent eQTL effects shared by both cell types in the multi-tissue analysis (Fig
2A). In the tissue-by-tissue analysis, expression levels of CTLA4were associated with 122 SNPs
(S3A Fig), including T1D and RA-associated variants rs231775 (+49A/G) [28], rs3087243
(CT60A/G) [28,30], rs231806 (MH30C/G) [28], and rs231735 [8] (pair-wise r2 between the
SNPs ranging from 0.51 to 0.90, and strong linkage disequilibrium (LD, r2 > 0.8) between
MH30 and CT60, S3C Fig). The CT60 polymorphism is also in strong LD with length variation
of the (AT)n repeat in the 3’UTR of CTLA4with long variants of the repeat associating with
lower CTLA4mRNA expression in autoimmune T cell clones [31]. Our results extend this find-
ing to the polyclonal population of CD4+ and CD8+ T cells, where the disease risk alleles were
associated with lower expression levels of CTLA4 (S3B Fig). Genetic control of the expression
eQTL analysis of CD4+ and CD8+ T cells
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of the alternatively spliced third exon, that is omitted from the secretory variant of CTLA4 [28],
was significantly detectable in CD4+ T cells only, whereas genetic association with the expres-
sion of the fourth exon was significant in both cell types (Fig 2B and 2E). Further investigation
of the CTLA4 gene locus revealed differential methylation between CD4+ and CD8+ T cells (Fig
2C). Specifically, methylation of a CpG site near the second exon of CTLA4 (cg26091609) was
inversely correlated with the expression levels of the three different probes in the gene (Fig 2D),
possibly explaining the expression differences in CD4+ and CD8+ T cells, and thus failing to
detect significant eQTL effects in the tissue-by-tissue analysis.
Interestingly, divergent DNA methylation between CD4+ and CD8+ T cells was similarly
detectable for an additional 73 out of 187 genes covered by more than one probe, and with
Fig 1. Summary of cis-eQTL analysis in CD4+ and CD8+ T cells. (A) Manhattan plots of the significant cis-eQTLs per gene in CD4+ (top) and CD8+ T cells
(bottom). The names of the top 50 genes per cell type are shown. (B) Examples of genes with cis-eQTLs: RP11−534L20.5 is located downstream of the
IKBKE gene which has an essential role in regulating inflammatory responses to viral infections; STAT6 is involved in T cell differentiation; and STX2 is
involved in intracellular transport of vesicles. The allelic effect of the SNPs on gene expression levels are shown by boxplots within violin plots. Violin plot
shows the density plot of the data on each side, the lower and upper border of the box correspond to the first and third quartiles, respectively, the central line
depicts the median, and whiskers extends from the borders to ±1.5xIQR, where IQR stands for inter-quantile range, the distance between the first and third
quantiles.
doi:10.1371/journal.pgen.1006643.g001
eQTL analysis of CD4+ and CD8+ T cells
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Fig 2. Probe-level differences between CD4+ and CD8+ T cells in the CTLA4 gene. (A) Overview of the CTLA4 gene locus. On the top panel the SNPs
associating with different isoform levels between the two cell types in the CTLA4 gene are depicted as grey bars, the gene transcripts are drawn, and the
positions of the three gene expression probes and four CpG sites in the region are shown at the bottom. (B) The expression levels (y-axis, quantile
eQTL analysis of CD4+ and CD8+ T cells
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seemingly isoform-specific eQTL effects (S3 Table). Among the 74 genes, multi-tissue analysis
resulted in the identification of eQTL effects for two or more probes in 66 genes which were
shared between the cell types. These observations suggest that the differential splicing effects,
plausibly regulated by epigenetic DNA methylation, influence the gene expression levels, and
thus the power to significantly detect eQTLs in the tissue-by-tissue analysis.
T cell specific trans-acting regulatory locus
For the analysis of SNPs affecting the expression of distal genes (>5 Mb apart), referred to as
trans-eQTLs, we selected all 4,638 genome-wide significant (P-value< 5x10-8) SNPs from the
GWAS catalog [32] (accessed 24/03/2015). After correcting gene expression levels for cis-
eQTL effects, we identified 36 and 40 GWAS SNPs associated with the expression levels of 209
and 378 distant genes in CD4+ and CD8+ T cells, respectively (overlap of 21 SNPs and 133
genes; Fig 3A, S4 Table). The functions of the genes associated with the trans-acting GWAS
SNPs highlighted their role in T1D (Ingenuity pathway analysis, P = 4.39x10-5, Fig 3A) and
mTOR signaling (P = 3.84x10-3, Fig 3A) in CD4+ and CD8+ T cells, respectively.
Strikingly, we observed a trans-acting regulatory locus at chr12q13.2 in CD4+ and CD8+ T
cells with broad-range impact on hundreds of genes. Five SNPs in that region were previously
implicated in B cell-specific trans-associations by Fairfax et al. [18]. In T cells, we identified the
lead SNP in this region as rs1131017 located in the 5´UTR of the ribosomal small subunit pro-
tein RPS26 gene (S5 Table). The rs1131017 SNP is in LD with eight GWAS SNPs implicated in
T1D [34,36,40], vitiligo [33,35] and other autoimmune and inflammatory diseases [30,37–39].
The pair-wise r2 values of the nine SNPs are shown in S4B Fig and their eQTL effects in S4C
Fig, illustrating the strong LD (r2 > 0.8) between the top trans-eQTL SNP rs1131017 and sev-
eral of the GWAS SNPs. In addition to RPS26, the trans-acting region contains the CDK2,
RAB5B, SUOX, IKZF4 and ERBB3 genes (S4A Fig) and associates with the expression levels of
187 and 351 genes in CD4+ and CD8+ T cells, respectively, with an overlap of 124 genes (Fig
3B). Many of these genes are highly expressed and have specific roles in T cells such as CTLA4,
GZMA, GZMB, GZMH, GNLY and CD8A (Fig 3B).
Missense variant in IL27 as a candidate disease variant for T1D
revealing significant trans-eQTL effects in CD4+ T cells
We also identified a trans-eQTL (GWAS SNP rs4788084[T]) on chr16p11.2 close to the IL27
gene associated with lower expression of IRF1 (P = 1.84x10-9) and STAT1 (P = 2.91x10-8) in
CD4+ T cells only. The rs4788084[T] is associated with lower expression of STAT1 in periph-
eral blood [16] and reduced risk for T1D [7,11]. To further explore the effects of genetic vari-
ants in the IL27 region, we mapped trans-eQTLs for all SNPs in the chromosome 16:28,2–29,1
Mb region (829 SNPs in total, S6 Table, Fig 4A).
This analysis revealed an even stronger trans-eQTL signal for a missense SNP rs181206[G]
within the IL27 gene (Fig 4B) and decreased expression levels of IRF1, STAT1 and REC8 (Fig 4C).
normalized and log2 transformed) for each of the probes are shown by boxplots for CD4+ and CD8+ T cells. The mean of the differences in expression levels
between CD4+ and CD8+ T cells are estimated by linear mixed models. (C) Methylation levels (y-axis) for each of the CpG sites along the genomic position
(x-axis) are shown by boxplots for CD4+ and CD8+ T cells. Medians of the methylation values per CpG sites are connected by a line in both cell types. The
mean of the differences in methylation levels between CD4+ and CD8+ T cells are estimated by linear mixed models. Only estimates with P-value < 0.05 are
marked on the figure. (D) Correlation between methylation and gene expression levels are shown on the scatter plot between the differentially methylated
CpG site cg26091609 for CD4+ and CD8+ T cells (y-axis) and three expression probes (x-axis). (E) The effect of rs3087243 on the expression levels (y-axis,
residual gene expression levels) of different probes in the CTLA4 gene are shown by boxplots within violin plots depicted as in Fig 1. Effect sizes and
corresponding P-values are reported for the multi-tissue and tissue-by-tissue analysis above and below of the violin plots, respectively. Significant eQTLs in
the tissue-by-tissue analysis are indicated with a star (*).
doi:10.1371/journal.pgen.1006643.g002
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The rs181206[G] allele, with a minor allele frequency of 29% in the 1000 Genomes phase 3 Euro-
pean population, causes the amino acid Leu119Pro change in the alpha-helical domain of IL-27
(S5 Fig). Strong LD (r2 ranges from 0.62 in the Estonian population to 0.84 in the other European
populations, 1000 Genomes phase 3) between rs181206 and the GWAS SNP rs4788084 supports
the protective role of the rs181206[G] allele for T1D among individuals of European ancestry. Of
note, the effect of the missense SNP on IRF1 and STAT1 remains after regressing out the effect of
the GWAS SNP, but not the other way around. Moreover, Bayesian test for colocalisation [41]
adds strength to the hypothesis that T1D susceptibility and changes of expression in IRF1 and
STAT1 are associated with the region, and share a single causal variant with the most posterior
support for rs181206[G] (S7 Table).
Importantly, despite the relatively small sample size, our focus on T cell subtypes enabled
us to identify this effect as specific to CD4+ T cells, as we did not detect significant trans-eQTL
effects in this region in CD8+ T cells (S6 Fig). We also confirmed the absence of the signal in B
cells and monocytes by re-analyzing the data from Fairfax et al. [18] (S6 Fig). Notably, the
trans-eQTL locus had no effects on the expression level of IL27 in cis (S7 Fig). In agreement
with the cell type-specific effect, we found higher expression levels of the IL27RA and IL6ST
(gp130) genes, which together act as a receptor for the IL-27 cytokine, in CD4+ cells in com-
parison to CD8+ T cells (Fig 4D).
Given the strong positive correlation between the expression levels of IRF1 and STAT1, we
used structural equation modeling to determine whether the IL27 SNP rs181206 affects both
genes independently or via each other. Overall, the best-fitting scenario suggested IRF1 to
mediate the SNP and STAT1 relationship (model 1, S8 Table). The finding was supported by a
simulation experiment (S8 Fig) and suggested a mechanism for the effect of IL-27 on IRF1 and
STAT1 expression (S9 Fig).
Functional effects of the IL27 missense SNP suggest causal role in
decreased expression of IRF1 and STAT1
In order to confirm the functional effect of the IL27 rs181206[G] allele we investigated its effect
on IRF1 and STAT1 expression in human PBMCs by additional experiments. IL-27 is produced
by innate immune cells, and after forming a heterodimer with EBI3, it interacts with its receptor
IL27RA and activates the STAT1/STAT3 pathway in T cells [42]. After binding to interferon
stimulated response elements (ISRE), the STAT1/STAT3 pathway induces transcription of sev-
eral interferon-induced genes, including IRF1 and STAT1 itself. We cloned cDNA variants of
the IL-27 wild-type (Leu119) and missense (Pro119), as well as EBI3. After transfection into
HEK293 cells, we combined the cell supernatants containing either IL-27 Leu119 or Pro119 pro-
tein with an equal amount of EBI3 protein and studied their effect on IRF1 and STAT1 expres-
sion by real-time PCR in human PBMCs from four healthy individuals.
Fig 3. Trans-associations in CD4+ and CD8+ T cells. (A) The outermost rim of the circos plot shows the histogram of the –log10(P-value) of the
associations between known genes and SNPs. Per every significant known gene only the highest –log10(P-value) is depicted. The innermost network
represents the trans-associations between the SNPs and the most significant gene expression probes per gene. The lines are colored by the chromosome of
the given SNP, except for the locus on chr12q13.2 with over 100 trans-associations that are colored in grey. An arbitrary selection of genes is depicted. All
genes not affected by chr12q13.2 SNPs are colored in black and a set of genes affected by chr12q13.2 trans-acting regulatory SNPs are selected based on
their known importance in immune system related processes and are colored in grey. The underlined genes are involved in T1D and mTOR signaling in
CD4+ T cells and CD8+ T cells, respectively. Two boxed genes among the genes with trans-eQTLs in CD4+ T cells are associated with the T1D susceptibility
variant rs4788084 close to the IL27 gene. (B) Heatmap of the correlation coefficients between chr12q13.2 trans-acting regulatory SNP allele dosages and
gene expression levels in CD4+ and CD8+ T cells are shown. The most significant gene expression probe per gene is chosen. An arbitrary selection of genes
based on their importance in immune system related processes are marked with black borders and gene symbol. The depicted SNPs are linked with their
role in disease susceptibility based on GWAS studies [30,33–40] and the numbers indicated in the lower panel refer to the same SNPs listed in the top panel.
doi:10.1371/journal.pgen.1006643.g003
eQTL analysis of CD4+ and CD8+ T cells
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As shown in Fig 4E, the missense SNP resulting in Pro119 in IL-27 induced lower STAT1
and IRF1 transcript levels compared to IL-27 Leu119. The comparison of the fixed effects of
the rs181206[G] allele resulted in highly significant estimates: b^mutant = -1.11 (P = 5.52x10
-13)
for IRF1 and b^mutant = -1.28 (P = 4.86x10
-10) for STAT1. This result supports our trans-eQTL
analysis, suggesting that the Pro119 in the IL27 gene is the causal SNP of these associations.
Discussion
We here report eQTL mapping in purified CD4+ and CD8+ T cells and reveal multiple effects
on regulation of genes associated with autoimmune diseases. The eQTL studies in cell subtypes
have both demonstrated a high level of specificity as their effects vary across cell types, as well
as remarkable sensitivity despite their several fold smaller sample sizes [24,25]. Indeed, we also
observed many cis-eQTLs identified in CD4+ and CD8+ T cells that were shared according to
the joint analysis, but were seemingly cell type-specific by the tissue-by-tissue analysis. The
genes with such notable patterns include CTLA4, known for its inhibitory role in T cell medi-
ated immune responses and association with many organ-specific autoimmune diseases [29].
The autoimmunity-susceptible SNPs in this region (rs231775, rs3087243, and rs231806) have
been associated with various functional effects including CTLA4 transcript levels, splicing, pro-
duction of the soluble form of CTLA-4 and posttranslational modifications [28,43–45]. In
addition, our results show differential DNA methylation in the CTLA4 region to be associated
with the potential isoform-specific differences in CD4+ and CD8+ T cells. This is likely due to
negative correlation between DNA methylation and gene expression, which eventually leads to
lower expression levels and moderate effect sizes. To confirm whether the observed effects are
due to true differences in isoforms instead of the quality of the designed probes at capturing
variation in gene expression levels, a follow-up study with RNA-seq data is needed.
The observed trans-acting regulatory region on chr12q13.2 in CD4+ and CD8+ T cells indi-
cates the important role of genetic variants in that region affecting the expression levels of over
a hundred genes across the genome. Interestingly, the region includes the RPS26 gene, which
may constitute a mechanism for the detected trans-eQTL effects. Our lead SNP rs1131017 is
located in an oligopyrimidine tract of the 5´UTR of the RPS26mRNA and its T1D risk allele
rs1131017[C] correlates positively with RPS26 expression levels [46,47]. The oligopyrimidine
tract controls the translation of many mammalian ribosomal protein genes [48], and the effect
of the SNP on RPS26 ribosomal distribution has been reported [49]. RPS26 is a main compo-
nent of the ribosomal region involved in the recruitment of cellular mRNA during transla-
tional initiation and in maintenance of the path of mRNA molecules to the ribosomal exit site
[50]. Hence, it is conceivable that changed RPS26 protein levels may affect the stability or
Fig 4. Trans associations with IRF1 and STAT1 gene expression levels in CD4+ T cells. (A) Regional association plots of the IL27 region SNPs with
association P-values for expression levels of IRF1 (chr5) and for STAT1 (chr2) in CD4+ T cells. The missense SNP rs181206 is used as the index SNP for
showing LD between the SNPs. (B) Overview of the IL27 transcripts and SNPs located in the IL27 gene region. In addition to the missense SNP rs181206,
other SNPs with the lowest association P-values in the upper LD cloud in panel (A) are intronic variants rs181203, rs181204, rs181207, rs181209, splice
region variant rs56354901, upstream gene variants rs62034318, rs79046494, and intergenic variant rs28449958. (C) The effect of the missense SNP
rs181206 on IRF1 and STAT1 gene expression levels are shown. P-values greater than 9.2x10-8 in CD8+ T cells resulted in FDR > 0.05 noted as NS (not
significant). (D) Expression levels (y-axis, quantile normalized and log2-transformed) grouped by cell type (x-axis) are shown for the three genes: IL27
(probe 6520523 in the last exon), IL27RA gene (probe 4250735 in 3’ downstream sequence), and IL6ST gene (probe 4010100 at the end of the last exon,
3830048 at the beginning of the last exon, 4260333 in the middle of the gene, from left to right). Linear mixed effects model is used to estimate the mean of
the differences in expression levels between CD4+ and CD8+ T cells. (E) The effect of the mutant and wild-type alleles of rs181206 on the expression
levels of IRF1 and STAT1. The log2 relative transcript levels (y-axis) are shown as a boxplot per allele and sample, with four samples in total. Every sample
was run in multiple parallel reactions, indicated by nm (number of mutant reactions) and nw (number of wild-type reactions), Sample1 was used in two
parallel sets. The mean expression in each class is shown by grey dashed lines, where m1 and m2 are indicating the mean among wild-type and mutant
samples, respectively. The effect of the mutant SNP on transcript levels is evaluated by linear mixed effects models. Boxplots within violin plots are
depicted as in Fig 1.
doi:10.1371/journal.pgen.1006643.g004
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translational efficiency of a large number of cytosolic mRNAs. Nevertheless, the exact func-
tional role of rs1131017[C] in T1D remains to be identified, as well as the effect of other candi-
date genes in this region such as IKZF4, ERBB3 [51] and CDK2 [52].
Strikingly, we identified a common missense variant in cytokine IL27 as a significant trans-
eQTL for IRF1 and STAT1 in CD4+ T cells. The effect of IL-27 in T cells is regarded as anti-
inflammatory but it has also been shown as a growth and survival factor for T cells [42]. As a
heterodimer with EBI3, IL-27 activates the STAT1/STAT3 pathway that induces the transcrip-
tion of several interferon-induced genes, including IRF1 and STAT1 itself. Our model suggests
that IRF1 mediates the effect of the IL27 SNP on expression levels of STAT1. Moreover, our
functional studies with the mutated form of IL-27 confirmed its decreased capacity to activate
the STAT1 pathway, and we showed that a potential causal variant (the missense variant
rs181206) for T1D susceptibility and changes in IRF1 and STAT1 expression is shared. Fur-
thermore, our findings are supported by studies of a T1D mouse model with high levels of IL-
27 and delayed T1D onset after treatment with an IL-27 blocking antibody [53]. Altogether
these results suggest that the rs181206[G] variant of the IL27 gene confers protection against
T1D through the inhibited expression of IRF1 and STAT1 in CD4+ T cells. Our results also
suggest that IL-27 may promote autoimmunity toward pancreatic islets via the upregulation of
the STAT1 pathway.
In conclusion, the analysis of genetic modulators of gene expression profiles as intermediate
phenotypes between human traits and underlying genetic variation offers new instruments to
refine our understanding of disease susceptibility. Moreover, eQTL studies in purified cell types
instead of whole blood enable us to establish the specific mechanisms and pathways involved in
diseases progression and create the basis for future explorations and drug interventions.
Materials and methods
Study design
The aims of this study were to perform cis- and trans-eQTL mapping in purified CD4+ and
CD8+ T cells and evaluate their pathogenic implications for autoimmune mechanisms. Based
on similar studies [18], we considered the sample size of 300 individuals to be sufficient to
ensure statistical power to detect eQTL effects in purified cells. This study participants were
healthy donors of the Estonian Genome Center of the University of Tartu [22]. In total, 313
subjects were selected for the study, with median age 54 (standard deviation 17.8), 154 females
and 159 males. The study was approved by the Ethics Review Committee of Human Research
of the University of Tartu, Estonia (permission no 206/T-4, date of issue 25.08.2011) and it
was carried out in compliance with the Helsinki Declaration. A written informed consent to
participate in the study was obtained from each individual prior to recruitment. All methods
were carried out in accordance with approved guidelines.
DNA from the samples were genotyped using HumanOmniExpress BeadChips (Illumina),
according to the manufacturer’s instructions. We imputed both datasets using the 1000
Genomes project reference by using IMPUTE v2 [54], resulting in 5,879,386 autosomal SNPs
with a minor allele frequency (MAF) of> 0.05 for downstream analyses. CD4+ and CD8+ T
cells were extracted from the peripheral blood mononuclear cells (PBMC) by consecutive posi-
tive separation using microbeads (CD4+ #130-045-101; CD8+ #130-045-201) and AutoMACS
technology (Miltenyi Biotec) according to the manufacturer’s protocol. Gene expression data
was generated using HumanHT-12v4 BeadChips (Illumina), according to the standard proto-
col. Preprocessing and quality control of the data was done using R [55] and the Bioconductor
packages lumi [56] and arrayQualityMetrics [57]. The number of samples retained for further
analysis was 293 for CD4+ and 283 for CD8+ T cells, 303 unique individuals. The effect of the
eQTL analysis of CD4+ and CD8+ T cells
PLOS Genetics | DOI:10.1371/journal.pgen.1006643 March 1, 2017 11 / 21
mutant and wild-type IL27 was experimentally tested in HEK 293 cells. The procedures are
described in details in the S1 File.
Cis- and trans-eQTL mapping
The effects of SNPs on local (cis-eQTL) and distant (trans-eQTL) genes were determined
via eQTL mapping as described in eQTL mapping analysis cookbook developed by the
University Medical Center Groningen at the Genetics Department and the Genomics
Coordination Center (https://github.com/molgenis/systemsgenetics/wiki/eQTL-mapping-
analysis-cookbook) and previously in [16]. For cis-analysis the distance between the probe
midpoint and SNP genomic location was up to 1 Mb and for trans-analysis the distance was
more than 5 Mb or the probe and SNP were on different chromosomes. Only SNPs with a
MAF > 0.05, call rate > 0.95 and a Hardy-Weinberg equilibrium P-value > 0.001 were
included in the analyses. We used the Spearman correlation coefficient (Spearman’s rho) to
detect associations between the coding allele of the SNP (directly genotyped or imputed
allele dosages) and the variations in gene expression levels (residual gene expression levels
obtained after corrections as described in “Gene expression quality control and normaliza-
tion” in Supplementary Methods). To control for multiple testing, we applied more conser-
vative probe-level false discovery rate (FDR) procedure. The eQTL mapping procedures are
described in details in the S1 File.
Proportion of true positives
To estimate the sharing of cis-eQTLs between the two cell types and peripheral blood we used
the π1 statistic (Storey and Tibshirani q-value approach [58] implemented in the R qvalue
package, default settings used). Based on the list of P-values, the overall proportion of true null
hypotheses (π0) is estimated, i.e. those following the Uniform(0,1) distribution. An estimate of
true alternative tests is π1 = 1 – π0, i.e. π1 is the proportion of true positives. The reported repli-
cation rate (proportion of sharing) between two groups (CD4+ or CD8+ T cells or pheripheral
blood) is the π1 statistic estimated by taking the significant SNP-probe list from one group and
using the corresponding P-value distribution in the other group.
Multi-tissue joint discovery of eQTLs
We used Bayesian framework for multi-tissue joint eQTL analysis by Flutre et al. [26] in CD4+
and CD8+ T cells implemented in the eQtlBma program. The cis candidate region was defined
as +/- 1 Mb from probe midpoint. As an input to the program, residual gene expression levels
obtained after corrections as described above and the corresponding genotypes were used.
Firstly, the raw Bayes factors for each configuration (eQTL active in CD4+, eQTL active in
CD8+, eQTL active in both cell types) were computed assessing the support in the data for
each probe-SNP pair being an eQTL. Secondly, information across all genes were combined
by the hierarchical model with an EM algorithm to get maximum-likelihood estimates of the
configuration probabilities. Thirdly, by Bayesian model averaging using the raw Bayes factors
weighted by the estimated configuration probabilities, the posterior probabilities for the eQTL
to be active in a given configuration were obtained. As a final result, only the best SNP per
probe is picked, based on the posterior probability for a SNP to be “the” eQTL for a probe. To
obtain the posterior probabilities, an estimate of the probability for a probe to have no eQTL
in any cell type (π0) is needed. This was estimated using Storey and Tibshirani q-value
approach [58] via probe-level P-values obtained by 10,000 permutations.
eQTL analysis of CD4+ and CD8+ T cells
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Pathway analysis
The Ingenuity Pathway Analysis (IPA) tool was used to establish associations with processes
and diseases. The standard IPA enrichment analysis was performed with the set of all human
genes on the Illumina array as background.
Bayesian test for colocalisation
The R package coloc [41] was used to assess whether two association signals are consistent with
a shared causal variant. Assuming a single causal SNP for both of the traits in a region, poste-
rior support for following hypothesis is estimated:
• H0: neither trait has a genetic association in the region;
• H1: only trait1 has a genetic association in the region;
• H2: only trait2 has a genetic association in the region;
• H3: both traits are associated, but with different causal variants;
• H4: both traits are associated and share a single causal variant.
For trait1, we chose T1D susceptibility and obtained necessary summary statistics from
Onengut-Gumuscu et al. [59] from www.t1dbase.org (accessed 13/09/2016) webpage. For
trait2, we chose the association with IRF1 and STAT1 expression in CD4+ T cells. Following
Giambartolomei et al. [41], we set prior probability (p1) that a variant is associated with trait1
to 10−4, prior probability (p2) for trans-eQTL effect to 10−5, and prior probability (p12) that a
variant is associated with both traits to 10−6. To show the consistency of the results, we varied
p2 and p12 values from 10−4 to 10−5 and 10−5 to 10−6, respectively.
Structural equation modeling (SEM) and mediation analysis
We compared the plausibility of potential models for the effects of the IL27 SNP on gene
expression levels of STAT1 and IRF1 using structural equation modeling (SEM). First, to test
the model’s concordance to the true population we used the chi-square test. Next, to assess the
goodness of fit of the resulting models, we used the following measures: Comparative Fit Index
(CFI), Tucker-Lewis Index (TLI) and Root Mean Square Error of Approximation (RMSEA).
The CFI and TLI goodness of fit measures indicate good models for values higher than 0.9.
RMSEA values less or equal to 0.05 indicate reasonable fit between the model and the data. To
compare the models, we used the Akaike information criterion (AIC). Lower values of that
theoretic measure indicate better models.
We applied the Sobel test to test whether a mediator carries the influence of the causal vari-
able to the outcome, i.e. testing whether the indirect effect of the causal variable on the out-
come via the mediator is significantly different from zero. The test statistic was calculated
using the Sobel formula [60]: ab=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
b2s2a þ a2s2b
p
, where a is the effect of the causal variable on
the mediator and b is the effect of the mediator on the outcome and sa and sb are the corre-
sponding standard errors of a and b.
IL27-IRF1-STAT1 simulation study
We conducted a simulation study to investigate the relationship between the coding allele of
the SNP and expression levels of two genes, IRF1 and STAT1. Therefore, we performed 1000
simulations using a sample size of n = 1000. We generated SNP genotypes with the minor allele
frequency being the sum of two random binary traits from a binomial distribution B(1, 0.37),
eQTL analysis of CD4+ and CD8+ T cells
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IRF1 expression levels depending only on the SNP (irf1 = 0.903 − 1.237 × snp + N(0,1)) and
STAT1 expression levels depending only on IRF1 expression levels (stat1 = 0.031 − 0.534 × irf1
+ N(0,1)). Then using simulated data, we estimated the significance of the SNP allelic effect
and IRF1 expression levels on STAT1 expression levels and the SNP allelic effect and STAT1
expression levels on IRF1 expression levels by linear models.
Graphics packages
Graphs were generated using R [55] base packages and ggplot2 [61]. The LD plots were gener-
ated using LDheatmap [62], the regional association plots were generated with Locus Zoom
[63] using hg19/1000 Genomes Nov 2014 EUR for showing LD between the variants, and the
circos plots were drawn using the Circos visualization tool [64].
Statistical analysis
We used linear mixed effects models to estimate the mean of the differences in methylation
and expression levels between CD4+ and CD8+ T cells assessing random intercepts for each of
the individuals adjusted for sex, age and batch effects (chip and position on chip). The effect of
the mutant SNP on IRF1 and STAT1 transcript levels was also evaluated by linear mixed effects
models.
Supporting information
S1 Fig. Estimated replication rate of peripheral blood cis-eQTLs in CD4+ and CD8+ T cells.
The histograms show the distribution of P-values of significant SNP-probe pairs (probe-level
FDR< 0.05) discovered in the meta-analysis by Westra et al. [16] in (A) CD4+ and (B) CD8+
T cells. The π1 statistic [58] estimates the proportion of true positives from the P-value distri-
bution, interpreted as the proportion of replicated cis-eQTL effects.
(TIF)
S2 Fig. Association between the eQTL effect size and gene expression levels. The scatterplot
shows the effect of the “best” SNP allele dosages on gene expression for 4385 significant probes
in CD4+ T cells (x-axis) and in CD8+ T cells (y-axis). For eQTLs where the absolute effect size
was higher in one cell type, there was also a tendency for higher expression levels in the given
cell type (chi-square test P-value < 2x10-16).
(TIF)
S3 Fig. Associations of the CTLA4 region SNPs with different expression probes in CTLA4
gene. (A) Regional association plots of the CTLA4 region (chr2:203,736–205,738 Mb) SNPs
with association P-values for gene expression levels of the three probes in the CTLA4 gene
(1230201, 4010768 and 6400333) in CD4+ and CD8+ T cells. The SNP rs3087243 is the lead
eQTL SNP and is used as the index SNP for showing linkage disequilibrium between the
SNPs. (B) Heatmap of the correlation coefficients between the T1D and/or RA-associated vari-
ants rs231735 [8], rs231806 [28] (MH30C/G), rs3087243 [28,30] (CT60A/G), rs231775 [28]
(+49A/G) and gene expression levels of the three different probes in the CTLA4 gene in CD4+
and CD8+ T cells. Allele in brackets indicates the assessed allele which is also the MAF allele.
(C) Linkage disequilibrium (LD) plot for the four T1D and/or RA-associated variants is
shown. LD between the SNPs is measured by pairwise r2 calculated using the genotypes of 99
individuals from 1000 Genomes project phase 3 CEU population. UCSC genes (based on
RefSeq) and their location with respect to SNPs are shown on the top of the LD plot. In the
Estonian population, the LD between rs231735 and rs231806, rs3087243 is stronger (r2 of 0.85
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and 0.76, respectively), the other r2 values are similar.
(TIF)
S4 Fig. Overview of the chr12q13.2 trans-acting locus. (A) Expression levels (y-axis, quantile
normalized and log2-transformed) of the six genes in the region by cell type (x-axis) are shown
by box plots incorporated into violin plots. Violin plot shows the density plot of the data on
each side, the lower and upper border of the box correspond to the first and third quartiles,
respectively, the central line depicts the median, and whiskers extends from the borders to +/-
1.5xIQR, where IQR stands for inter-quantile range, the distance between the first and third
quantiles. (B) Linkage disequilibrium (LD) plot for the lead eQTL SNP and eight GWAS SNPs
on chromosome 12 trans-acting region chr12q13.2 is shown. The GWAS SNPs are linked with
their role in disease susceptibility in Fig 3. LD between the SNPs is measured by pairwise r2
calculated from 99 individuals from 1000 Genomes project phase 3 CEU population. UCSC
genes (based on RefSeq) and their location with respect to SNPs are shown on the top of the
LD plot. There is strong LD (r2 > 0.8) between the lead eQTL SNP rs1131017 and three
GWAS SNPs rs10876864, rs11171739 and rs773125 (r2 of 1.00, 0.92 and 0.88, respectively, in
CEU population and r2 of 0.98, 0.98 and 0.84, respectively, in the Estonian population). (C)
Regional association plots including all SNPs at chr12q13.2. The smallest association P-values
for the SNPs are shown in CD4+ and CD8+ T cells. The SNP rs1131017 is the lead SNP in the
region with the smallest P-value, and the eight GWAS SNPs are highlighted.
(TIF)
S5 Fig. Structure model of the human IL-27 (Q8NEV9; residues 61 to 134, based on http://
www.proteinmodelportal.org/) and location of the amino acid lysine (L119) that is
changed to proline (P119) by the rs181206 missense mutation. We identified a common
missense variant rs181206[A/G] in cytokine IL27 as a trans-eQTL for IRF1 and STAT1 in
CD4+ T cells. The G allele of the variant alters an amino acid in the alpha-helical domain from
leucine to proline at position 119.
(TIF)
S6 Fig. Associations of the IL27 region SNPs with IRF1 and STAT1 gene expression levels
in CD8+ T cells, B cells and in monocytes. Regional association plots of the IL27 region
(chr16:28,2–29,1 Mb) SNPs with association P-values for (A) IRF1 (chr5) and (B) STAT1
(chr2) gene expression levels in CD8+ T cells, B cells, and monocytes. The SNP rs181206 is
used as the index SNP for showing linkage disequilibrium between the SNPs.
(TIF)
S7 Fig. Associations of the IL27 region SNPs with IL27 gene expression levels in CD4+ T
cells, CD8+ T cells, B cells and in monocytes. Regional association plots of the IL27 region
(chr16:28,2–29,1 Mb) SNPs with association P-values for the IL27 gene expression levels in
CD4+ T cells, CD8+ T cells, B cells, and monocytes. The SNP rs181206 is used as the index
SNP for showing linkage disequilibrium between the SNPs.
(TIF)
S8 Fig. Comparison of two models IRF ~ STAT1 + SNP and STAT1 ~ IRF1 + SNP on
observed and simulated data. We performed 1000 simulations using a sample size of
n = 1000. We generated SNP genotypes, IRF1 and STAT1 expression levels according to the
plausible causal model 1) SNP -> IRF1 -> STAT1 as follows: we generated SNP genotypes
with minor allele frequency as the sum of a two random binary traits from binomial distribu-
tion B(1, 0.37), IRF1 expression levels depending only on the SNP (irf1 = 0.903–1.237 x snp +
N(0,1)) and STAT1 expression levels depending only on IRF1 expression levels (stat1 = 0.031
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+ 0.534 x irf1 + N(0,1)). Then using simulated and observed data, we compared the estimates
obtained from two linear models IRF ~ STAT1 + SNP (upper panel) and STAT1 ~ IRF1
+ SNP (lower panel). Parameter estimates with 95% confidence intervals are shown for every
explanatory variable for observed and simulation data. A similar pattern of the parameter esti-
mates supports the validity of causal model 1).
(TIF)
S9 Fig. A scheme on IL-27 role in activation of IRF1 and STAT1 gene expression. IL27 (as a
heterodimer with EBI3), upon binding to its receptor, activates the STAT1/STAT3 pathway.
After binding to interferon stimulated response elements (ISRE), STAT1/STAT3 pathway
induces transcription of several interferon-induced genes, including IRF1 and STAT1 itself.
IRF1 is a transcription factor that enhances the expression of STAT1 gene. We identified a
common missense variant in cytokine IL27 as a trans-eQTL for IRF1 and STAT1 in CD4+ T
cells. Our model suggests that IRF1 mediates the SNP and STAT1 relationship. Moreover, our
functional studies with the mutated form of IL-27 (that is associated with protection against
T1D via linkage disequilibrium with GWAS SNP rs4788084) confirmed its decreased capacity
to activate the STAT1 pathway.
(TIF)
S1 Table. Significant cis-eQTL effects in CD4+ and CD8+ T cells (probe-level false discov-
ery rate < 0.05).
(XLSX)
S2 Table. Significant results of multi-tissue joint analysis (FDR < 0.05). Bayesian model
averaging and hierarchical modelling framework by Flutre et al. was used implemented in the
eQtlBma program. Only the best SNP per probe is picked, based on the posterior probability
for a SNP to be “the” eQTL for that probe. Posteriors of all configurations together with sum-
mary statistics in CD4+ and CD8+ T cells are reported. There are 4385 probes with eQTLs
within 3871 genes (FDR< 0.05).
(XLSX)
S3 Table. Significant differences in DNA methylation levels between CD4+ and CD8+ T
cells among genes with seemingly isoform-specific effects between the two cell types. There
were 408 out of 3,024 genes affected by a SNP which were covered by more than one expres-
sion probe with cis-eQTL effects in CD4+ and/or CD8+ T cells. We could find CpG sites in the
proximity (+/- 1000 basepairs) of the gene for 405 genes covered by 8665 CpG sites. We tested
those CpG sites for differential methylation between CD4+ and CD8+ T cells. The effect on the
mean of the differences in CD8+ compared to CD4+ T cells was evaluated using linear mixed
models. False discovery rate based multiple testing was used based on all tested CpG sites.
CpG sites with the most significant differences in methylation are listed per 74 gene out of 187
with seemingly isoform-specific effects in the tissue-by-tissue analysis. Multi-tissue analysis
could find eQTL effect for two or more probes in 66 genes (of the 74 genes) with high posterior
confidence to be shared between the two cell types.
(XLS)
S4 Table. Significant trans-eQTL effects with SNPs associated with human diseases or
traits in CD4+ and CD8+ T cells (probe-level false discovery rate < 0.05).
(XLS)
S5 Table. Significant trans-eQTL effects with SNPs at chr12q13.2 in CD4+ and CD8+ T
cells (probe-level false discovery rate < 0.05).
(XLS)
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S6 Table. IL27 region trans-eQTL mapping results for the IRF1 and STAT1 genes in CD4+
T cells, CD8+ T cells, monocytes, and B cells.
(XLS)
S7 Table. T1D/eQTL colocalisation. Results of the colocalisation analysis between the trans-
eQTLs for IRF1 (A) and STAT1 (B) in CD4+ T cells and the type 1 diabetes (T1D) susceptibility
using different prior probabilities. The columns “T1D pval” and “eQTL pval” note the lowest P-
value found for the association with T1D from Onengut-Gumuscu et al. study using T1DBase
database (www.t1dbase.org), and for the expression association in CD4+ T cells respectively,
with the corresponding SNP name (“T1D SNP” and “eQTL SNP”), “Best Causal” reports the
SNP with the highest posterior probability to be the true causal variant among the two. Different
prior probabilities for observing trans-eQTL effect (p2) and different prior probabilities for the
variant being associated with both traits (p12) are used to estimate the poster probability for dif-
ferent signal (different causal variant for associated traits, PP3) and common signal (shared sin-
gle causal variant for associated traits, PP4).
(DOCX)
S8 Table. SEM fit statistics for three alternative causal models. To test the model’s concor-
dance to true population we used chi-square test. To assess the goodness of fit of the resulting
models, we used the following measures: Comparative Fit Index (CFI), Tucker-Lewis Index
(TLI) and Root Mean Square Error of Approximation (RMSEA). The CFI and TLI goodness
of fit measures indicate good models for values higher than 0.9. RMSEA values less or equal to
0.05 indicate reasonable fit between the model and the data. To compare models we used the
Akaike information criterion (AIC). Lower values of the theoretic measures indicate better
models.
(DOCX)
S1 File. Supplementary material and methods.
(PDF)
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